Supplemental material
Open access
1,754
Views
0
CrossRef citations to date
0
Altmetric
Article
Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies
Eric L. Simpsona Department of Dermatology, Oregon Health & Science University, Portland, OR, USAView further author information
, Robert Bissonnetteb Innovaderm Research, Montreal, Quebec, CanadaView further author information
, Zelma C. Chiesa Fuxenchc Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USAView further author information
, Howard Kallenderd Incyte Corporation, Wilmington, DE, USAView further author information
, Daniel Sturmd Incyte Corporation, Wilmington, DE, USAView further author information
, Haobo Rend Incyte Corporation, Wilmington, DE, USAView further author information
& Linda F. Stein Golde Henry Ford Health System, Detroit, MI, USACorrespondence[email protected]
View further author information
show allView further author information
Article: 2310633
|
Received 01 Oct 2023, Accepted 22 Jan 2024, Published online: 31 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.